Neuropeptide Y (NPY) modulates oxidative burst and nitric oxide production in carrageenan-elicited granulocytes from rat air pouch

Peptides

Volumn 27, Issue 12, 2006, Pages 3208-3215

  Dimitrijević, Mirjana ^a   Stanojević, Stanislava ^a   Mićić, Stana ^a   Vujić, Vesna ^b   Kovačević Jovanović, Vesna ^a   Mitić, Katarina ^a   von Hörsten, Stephan ^c   Kosec, Duško ^a  

^a Immunology Research Center Belgrade   (Yugoslavia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Granulocytes; Inflammation; Neuropeptide Y (NPY); NPY receptors; Rat

Indexed keywords

CARRAGEENAN; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y3 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NITRIC OXIDE; PEPTIDE DERIVATIVE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GRANULOCYTE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; RESPIRATORY BURST;

EID: 33750959354     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.08.018     Document Type: Article

References (33)

1. Ahmed A.A., Wahbi A., Nordlind K., Kharazmi A., Sundqvist K.G., Mutt V., et al. In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand J Immunol 48 (1998) 79-85
2. Bedoui S., Lechner S., Gebhardt T., Nave H., Beck-Sickinger A.G., Straub R.H., et al. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J Neuroimmunol 132 (2002) 25-33
3. Bedoui S., Kawamura N., Straub R.H., Pabst R., Yamamura T., and von Hörsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol 134 (2003) 1-11
4. Bedoui S., Kuhlmann S., Nave H., Drube J., Pabst R., and von Hörsten S. Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B lymphocytes and activated monocytes. J Neuroimmunol 117 (2001) 125-132
5. Bedoui S., Myake S., Lin Y., Myamoto K., Oki S., Kawamura N., et al. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol 171 (2003) 3451-3458
6. Cabrele C., Langer M., Bader R., Wieland H.A., Doods H.N., Zerbe O., et al. The first selective agonist at the neoropeptide Y Y5-receptor increases food intake in rats. J Biol Chem 275 (2000) 36043-36048
7. De la Fuente M., Bernaez I., Del Rio M., and Hernanz A. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology 80 (1993) 259-265
8. De la Fuente M., Del Río M., and Medina S. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J Neuroimmunol 116 (2001) 156-167
9. Dimitrijević M., Stanojević S., Vujić V., Beck-Sickinger A., and von Hörsten S. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage function in vitro: counter regulation through Y1 and Y2/5 receptors. Regul Pept 124 (2005) 163-172
10. Dimitrijević M., Stanojević S., Vujić V., Kovačević-Jovanović V., Beck-Sickinger A., Demuth H.-U., et al. Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26). J Neuroimmunol 129 (2002) 35-42
11. Dumont Y., Cadieux A., Doods H., Pheng L.A., Abounader R., Hamel E., et al. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y2 receptor antagonist. Br J Pharmacol 129 (2000) 1075-1088
12. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 (2000) 595-638
13. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., and Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135 (1985) 755s-765s
14. Felten S.Y., and Olschowka J. Noradrenergic sympathetic innervation of the spleen: II Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic like contacts on lymphocytes in the splenic white pulp. J Neurosci Res 18 (1987) 37-48
15. 15 Nnitrate in biological fluids. Anal Biochem 126 (1982) 131-138
16. Hassani H., Lucas G., Rozell B., and Ernfors P. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Am J Physiol Gastrointest Liver Physiol 288 (2005) G550-G556
17. Hickey M.J., Granger D.N., and Kubes P. Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol Scand 173 (2001) 119-126
18. Kanatani A., Isihara A., Iwaasa H., Nakamura K., Okamoto O., Hidaka M., et al. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist. Biochem Biophys Res Commun 272 (2000) 169-173
19. Levite M., Cahalon L., Hershkoviz R., Steinman L., and Lider O. Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J Immunol 160 (1998) 993-1000
20. Lin Q., You X., Ren Y., Wang J., Fang L., and Willis W.D. Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin. Neuroscience 123 (2004) 337-347
21. Madden K.S. Catecholamines, sympathetic nerves, and immunity. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology (2001), Academic Press, San Diego 197-230
22. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85 (1999) 9-24
23. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., et al. XVI International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY and pancreatic polypeptide receptors. Pharmacol Rev 50 (1998) 143-150
24. Nan Y.-S., Feng G.-G., Hotta Y., Nishiwaki K., Shimada Y., Ishikawa A., et al. Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer. Am J Physiol Circ Physiol 286 (2004) H1027-H1033
25. Nave H., Bedoui S., Moenter F., Steffens J., Felies M., Gebhardt T., et al. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. J Neuroimmunol 155 (2004) 1-12
26. Nilsson T., Lind H., Brunkvall J., and Edvinsson L. Vasodilatation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent. Can J Pharmacol 78 (2000) 251-255
27. Pick E., Charon J., and Mizel D. A rapid densitometric microassay for the nitroblue tetrazolium reduction and application of the microassay to macrophages. J Reticuloendothel Soc 30 (1981) 581-593
28. Pick E., and Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 46 (1981) 211-226
29. Stanojević S, Vujić V, Kovačević-Jovanović V, Mitić K, Kosec D, von Hörsten S, et al. Age-related effect of PYY on paw edema in the rat: the function of Y1 receptors on inflammatory cells. Exp Gerontol 2006;41:793-9.
30. Straub R.H., Westermann J., Schölmerich J., and Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today 19 (1998) 409-413
31. Wheway J., Mackay C.R., Newton R.A., Sainsbury A., Boey D., Herzog H., et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 202 (2005) 1527-1538
32. Wiest R., Jurzik L., Moleda L., Froh M., Schnabl B., von Hörsten S., et al. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension. J Hepatol 44 (2006) 512-519
33. Zukowska-Grojec Z. Neuropeptide Y: an adrenergic cotransmitter, vasoconstrictor, and nerve-derived vascular growth factor. Adv Pharmacol 42 (1998) 125-128